Vectorite Biomedical Inc. (TPEX:4170)

Vectorite Biomedical Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	683	635	935	621	621	492
Market Cap Growth	7.22%	-32.08%	50.46%	-	26.25%	-21.38%
Enterprise Value	507	442	728	396	375	526
Last Close Price	15.60	14.50	21.35	14.01	14.01	14.01
PE Ratio	-	-	-	-	74.32	-
PS Ratio	10.06	10.99	16.73	14.47	21.59	20.05
PB Ratio	1.74	1.63	2.17	1.41	1.33	1.43
P/TBV Ratio	1.76	1.66	2.29	1.49	1.40	1.56
P/FCF Ratio	-	-	-	44.96	-	-
P/OCF Ratio	-	-	719.97	42.25	-	-
EV/Sales Ratio	7.47	7.65	13.04	9.23	13.03	21.44
EV/FCF Ratio	-49.93	-	-	28.67	-	-
Debt / Equity Ratio	0.00	-	-	-	-	-
Asset Turnover	0.16	0.13	0.12	0.09	0.07	0.07
Inventory Turnover	2.59	3.29	5.31	6.99	4.97	3.72
Quick Ratio	12.20	12.91	16.45	14.10	14.53	6.28
Current Ratio	13.46	14.06	17.53	14.93	15.07	6.74
Return on Equity (ROE)	-5.73%	-9.77%	-1.52%	-5.83%	2.05%	-20.93%
Return on Assets (ROA)	-2.65%	-3.75%	-2.20%	-3.98%	-6.15%	-10.05%
Return on Invested Capital (ROIC)	-8.34%	-12.03%	-7.09%	-13.41%	-17.57%	-24.34%
Return on Capital Employed (ROCE)	-4.50%	-6.50%	-3.70%	-6.80%	-8.90%	-17.20%
Earnings Yield	-3.40%	-6.31%	-0.71%	-4.25%	1.35%	-13.86%
FCF Yield	-1.49%	-2.26%	-0.37%	2.22%	-10.88%	-7.66%
Buyback Yield / Dilution	0.14%	0.14%	-	-1.84%	-47.01%	-14.34%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.